Some Oklahoma children will get a swine flu vaccine before it is available to the public. If clinical trials go well, the vaccine could be available in limited supplies by mid to late fall, experts said.
But some officials fear the already fast-tracked studies may not be swift enough to curb the disease’s quick spread.
IPS Research in Oklahoma City is the first Oklahoma company to conduct the vaccination trials and will begin enrolling study patients Aug. 17, said IPS Research medical director Dr. Louise Thurman.
The trials will test the vaccine’s effectiveness and whether or not it has negative side effects in patients.
She anticipates about 200 children ages 3 to 8 will be able to enroll.